John Jenkins
Director/Board Member presso CORBUS PHARMACEUTICALS HOLDINGS, INC.
Patrimonio netto: 1 295 $ in data 31/03/2024
Profilo
John Kenneth Jenkins is currently a Director at Corbus Pharmaceuticals, Inc., an Independent Director at Corbus Pharmaceuticals Holdings, Inc., and a Principal-Drug & Biological Products at Greenleaf Health Inc. Previously, he was the Director-Acting Division at the US Food & Drug Administration from 1992 to 2002, and the Director-New Drugs at the Center for Drug Evaluation & Research from 2002 to 2017.
He was also an Independent Director at Provention Bio, Inc. from 2020 to 2023.
Additionally, he worked as an Assistant Professor at Virginia Commonwealth University Health System.
Jenkins holds a doctorate degree from the University of Tennessee.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
22/03/2024 | 33 ( 0.00% ) | 1 295 $ | 31/03/2024 |
Posizioni attive di John Jenkins
Società | Posizione | Inizio |
---|---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 05/06/2018 |
Greenleaf Health Inc.
Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kinsale Holdings, Inc., Greenleaf Health Inc. is a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. The private company is based in Washington. Greenleaf is guided by experts with a combined total of more than 300 years of FDA experience, including former leaders throughout the agency. The American company was founded in 2007 by Patrick Ronan. Greenleaf Health was acquired by Kinsale Holdings, Inc. on April 19, 2021. | Corporate Officer/Principal | 01/02/2019 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Director/Board Member | - |
Precedenti posizioni note di John Jenkins
Società | Posizione | Fine |
---|---|---|
PROVENTION BIO, INC. | Director/Board Member | 27/04/2023 |
Center for Drug Evaluation & Research | Corporate Officer/Principal | 01/01/2017 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | 01/01/2002 |
Virginia Commonwealth University Health System
Virginia Commonwealth University Health System Miscellaneous Commercial ServicesCommercial Services Virginia Commonwealth University Health System operates hospitals and outpatient clinics. Its medical services cover areas such as organ transplantation, head and spinal cord trauma, burn healing, and cancer treatment. The company was founded in 1838 and is headquartered in Richmond, VA. | Corporate Officer/Principal | - |
Formazione di John Jenkins
University of Tennessee | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Virginia Commonwealth University Health System
Virginia Commonwealth University Health System Miscellaneous Commercial ServicesCommercial Services Virginia Commonwealth University Health System operates hospitals and outpatient clinics. Its medical services cover areas such as organ transplantation, head and spinal cord trauma, burn healing, and cancer treatment. The company was founded in 1838 and is headquartered in Richmond, VA. | Commercial Services |
Center for Drug Evaluation & Research | Government |
Greenleaf Health Inc.
Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kinsale Holdings, Inc., Greenleaf Health Inc. is a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. The private company is based in Washington. Greenleaf is guided by experts with a combined total of more than 300 years of FDA experience, including former leaders throughout the agency. The American company was founded in 2007 by Patrick Ronan. Greenleaf Health was acquired by Kinsale Holdings, Inc. on April 19, 2021. | Commercial Services |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
- Borsa valori
- Insiders
- John Jenkins